Anixa Biosciences (ANIX) Other Working Capital Changes (2010 - 2025)

Anixa Biosciences (ANIX) has reported Other Working Capital Changes for 16 consecutive years, with -$707000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Other Working Capital Changes fell 123.73% year-over-year to -$707000.0; the trailing twelve-month figure through Oct 2025 stood at -$552000.0 (down 1183.72% YoY), and the FY2025 full-year result was -$552000.0, down 1183.72% from the prior year.
• Other Working Capital Changes retreated to -$707000.0 in Q4 2025 per ANIX's latest filing, from $251000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $758000.0 in Q3 2024 and bottomed at -$707000.0 in Q4 2025.
• Historically, Other Working Capital Changes has averaged $16650.0 across 5 years, with a median of -$104000.0 in 2022.
• The sharpest annual moves came in 2021 and 2023: Other Working Capital Changes sank 651.48% in 2021, then soared 469.79% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$174000.0 in 2021, then dropped by 10.34% to -$192000.0 in 2022, then jumped by 469.79% to $710000.0 in 2023, then plunged by 144.51% to -$316000.0 in 2024, then plunged by 123.73% to -$707000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$707000.0, $251000.0, and -$262000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.